Genomma Lab Internacional. de Future Growth
Future criteria checks 4/6
Genomma Lab Internacional. de is forecast to grow earnings and revenue by 26.7% and 8% per annum respectively. EPS is expected to grow by 1.8% per annum. Return on equity is forecast to be 15.5% in 3 years.
Key information
26.7%
Earnings growth rate
1.8%
EPS growth rate
Pharmaceuticals earnings growth | 20.6% |
Revenue growth rate | 8.0% |
Future return on equity | 15.5% |
Analyst coverage | Low |
Last updated | 26 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 20,744 | 2,624 | 2,078 | N/A | 2 |
12/31/2025 | 19,185 | 2,236 | 1,857 | N/A | 3 |
12/31/2024 | 18,203 | 2,175 | 1,667 | N/A | 2 |
3/31/2024 | 16,486 | 1,045 | 1,752 | 1,810 | N/A |
12/31/2023 | 16,467 | 1,031 | 2,165 | 2,254 | N/A |
9/30/2023 | 17,074 | 1,392 | 1,436 | 1,775 | N/A |
6/30/2023 | 17,030 | 1,421 | 1,133 | 1,519 | N/A |
3/31/2023 | 17,022 | 1,416 | 1,047 | 1,321 | N/A |
12/31/2022 | 16,820 | 1,389 | 1,632 | 2,055 | N/A |
9/30/2022 | 16,778 | 1,359 | 1,821 | 2,409 | N/A |
6/30/2022 | 16,412 | 1,353 | 1,895 | 2,559 | N/A |
3/31/2022 | 15,954 | 1,328 | 1,593 | 2,327 | N/A |
12/31/2021 | 15,487 | 1,308 | 632 | 1,468 | N/A |
9/30/2021 | 14,868 | 1,352 | 778 | 1,495 | N/A |
6/30/2021 | 14,312 | 1,368 | 572 | 1,283 | N/A |
3/31/2021 | 14,083 | 1,416 | 580 | 1,316 | N/A |
12/31/2020 | 13,870 | 1,404 | 1,010 | 1,715 | N/A |
9/30/2020 | 13,619 | 1,179 | 404 | 1,268 | N/A |
6/30/2020 | 13,268 | 1,003 | 522 | 1,337 | N/A |
3/31/2020 | 12,910 | 886 | 494 | 1,277 | N/A |
12/31/2019 | 12,713 | 750 | 130 | 1,007 | N/A |
9/30/2019 | 12,617 | 935 | 66 | 1,319 | N/A |
6/30/2019 | 12,274 | 925 | -335 | 1,229 | N/A |
3/31/2019 | 11,921 | 986 | -87 | 1,551 | N/A |
12/31/2018 | 11,794 | 1,109 | 50 | 1,562 | N/A |
9/30/2018 | 11,556 | 1,242 | 418 | 1,352 | N/A |
6/30/2018 | 11,900 | 1,249 | 692 | 1,214 | N/A |
3/31/2018 | 11,886 | 1,218 | 806 | 1,189 | N/A |
12/31/2017 | 12,078 | 1,279 | N/A | 1,392 | N/A |
9/30/2017 | 11,898 | 958 | N/A | 1,293 | N/A |
6/30/2017 | 11,741 | 1,212 | N/A | 1,326 | N/A |
3/31/2017 | 11,669 | -1,603 | N/A | 1,459 | N/A |
12/31/2016 | 11,316 | -1,681 | N/A | 1,543 | N/A |
9/30/2016 | 11,287 | -3,447 | N/A | 1,388 | N/A |
6/30/2016 | 10,988 | -3,759 | N/A | 1,571 | N/A |
3/31/2016 | 11,125 | -895 | N/A | 587 | N/A |
12/31/2015 | 11,042 | -1,137 | N/A | 1,188 | N/A |
9/30/2015 | 11,211 | 1,109 | N/A | 1,577 | N/A |
6/30/2015 | 11,946 | 1,410 | N/A | 1,600 | N/A |
3/31/2015 | 11,871 | 1,396 | N/A | 1,338 | N/A |
12/31/2014 | 11,541 | 1,432 | N/A | 1,039 | N/A |
9/30/2014 | 12,375 | 1,776 | N/A | 1,081 | N/A |
6/30/2014 | 12,082 | 1,766 | N/A | 1,230 | N/A |
3/31/2014 | 11,715 | 1,775 | N/A | 1,898 | N/A |
12/31/2013 | 11,361 | 1,752 | N/A | 1,871 | N/A |
9/30/2013 | 11,072 | 1,663 | N/A | 1,502 | N/A |
6/30/2013 | 10,567 | 1,610 | N/A | 1,046 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GEKA's forecast earnings growth (26.7% per year) is above the savings rate (0.6%).
Earnings vs Market: GEKA's earnings (26.7% per year) are forecast to grow faster than the German market (15% per year).
High Growth Earnings: GEKA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: GEKA's revenue (8% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: GEKA's revenue (8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GEKA's Return on Equity is forecast to be low in 3 years time (15.5%).